Chronos Therapeutics is a biotechnology company operating a semi-virtual research and development model. It focuses on degenerative and behavioral diseases of the brain and nervous system via acquisition, discovery, and development of lead candidates, as well as repositioning FDA/EMA approved drugs. The company uses its Chronoscreen platform to do research.